Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernest Nadal

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
Seminars in Cell & Developmental Biology|June 26, 2019
Exploiting metabolic vulnerabilities of Non small cell lung carcinomaBlanca Majem, Ernest Nadal, Cristina Muñoz-Pinedo
Oncogenesis|May 20, 2026
Metabolic vulnerabilities in pleural mesotheliomaSílvia Plans-Marin, Cristina Muñoz-Pinedo, Ernest Nadal
Translational Lung Cancer Research|February 11, 2021
Induction treatment in patients with stage III non-small cell lung cancerRamón Palmero, Noelia Vilariño, Arturo Navarro-Martín, et al.
Trends in Cancer|December 14, 2020
Targeting Infrequent Driver Alterations in Non-Small Cell Lung CancerMarie-Julie Nokin, Chiara Ambrogio, Ernest Nadal, et al.
Lung Cancer (Amsterdam, Netherlands)|April 17, 2018
Successful treatment with brigatinib in a patient with ALK-rearranged lung adenocarcinoma who developed crizotinib-induced interstitial lung diseaseMarta Doménech, Maria Jové, Samantha Aso, et al.
Translational Lung Cancer Research|February 11, 2021
Systematic review of stereotactic body radiotherapy in stage III non-small cell lung cancerOlwen Leaman Alcibar, Ernest Nadal, Inmaculada Romero Palomar, et al.
Cancer Immunology, Immunotherapy : CII|February 7, 2019
Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivorsErnest Nadal, Bartomeu Massuti, Manuel Dómine, et al.
Cells|March 29, 2023
<i>BAP1</i> Malignant Pleural Mesothelioma Mutations in <i>Caenorhabditis elegans</i> Reveal Synthetic Lethality between <i>ubh-4</i>/<i>BAP1</i> and the Proteasome Subunit <i>rpn-9</i>/<i>PSMD13</i>Carmen Martínez-Fernández, Sweta Jha, Elisabet Aliagas, et al.
Lung Cancer (Amsterdam, Netherlands)|August 21, 2021
On target: Rational approaches to KRAS inhibition for treatment of non-small cell lung carcinomaColin R Lindsay, Marina C Garassino, Ernest Nadal, et al.
Neuro-Oncology Advances|September 9, 2024
Mitigating radiation-induced cognitive toxicity in brain metastases: More questions than answersMarta Simó, Antoni Rodríguez-Fornells, Valentín Navarro, et al.
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
Seminars in Cell & Developmental Biology|June 26, 2019
Exploiting metabolic vulnerabilities of Non small cell lung carcinomaBlanca Majem, Ernest Nadal, Cristina Muñoz-Pinedo
Oncogenesis|May 20, 2026
Metabolic vulnerabilities in pleural mesotheliomaSílvia Plans-Marin, Cristina Muñoz-Pinedo, Ernest Nadal
Translational Lung Cancer Research|February 11, 2021
Induction treatment in patients with stage III non-small cell lung cancerRamón Palmero, Noelia Vilariño, Arturo Navarro-Martín, et al.
Trends in Cancer|December 14, 2020
Targeting Infrequent Driver Alterations in Non-Small Cell Lung CancerMarie-Julie Nokin, Chiara Ambrogio, Ernest Nadal, et al.
Lung Cancer (Amsterdam, Netherlands)|April 17, 2018
Successful treatment with brigatinib in a patient with ALK-rearranged lung adenocarcinoma who developed crizotinib-induced interstitial lung diseaseMarta Doménech, Maria Jové, Samantha Aso, et al.
Translational Lung Cancer Research|February 11, 2021
Systematic review of stereotactic body radiotherapy in stage III non-small cell lung cancerOlwen Leaman Alcibar, Ernest Nadal, Inmaculada Romero Palomar, et al.
Cancer Immunology, Immunotherapy : CII|February 7, 2019
Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivorsErnest Nadal, Bartomeu Massuti, Manuel Dómine, et al.
Cells|March 29, 2023
<i>BAP1</i> Malignant Pleural Mesothelioma Mutations in <i>Caenorhabditis elegans</i> Reveal Synthetic Lethality between <i>ubh-4</i>/<i>BAP1</i> and the Proteasome Subunit <i>rpn-9</i>/<i>PSMD13</i>Carmen Martínez-Fernández, Sweta Jha, Elisabet Aliagas, et al.
Lung Cancer (Amsterdam, Netherlands)|August 21, 2021
On target: Rational approaches to KRAS inhibition for treatment of non-small cell lung carcinomaColin R Lindsay, Marina C Garassino, Ernest Nadal, et al.
Neuro-Oncology Advances|September 9, 2024
Mitigating radiation-induced cognitive toxicity in brain metastases: More questions than answersMarta Simó, Antoni Rodríguez-Fornells, Valentín Navarro, et al.
Pageof 17